Trial intelligence / Profile preview

Del Nido vs Cold Blood Cardioplegia in Aortic Valve Replacement

NCT03818126Completed

Start
Jul 2016
Primary completion
Jun 2018
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

Randomised, open-label trial of del Nido cardioplegia in ischemia-reperfusion injury (IRI) (2 arms). Primary endpoints: Electrical cardiac activity during cross-clamp, Ventricular fibrillation during reperfusion and 2 more. Started Jul 2016; status: completed.

02

Drugs

del Nido cardioplegia
03

Conditions

ischemia-reperfusion injury (IRI)

Beyond the preview

Go deeper on NCT03818126.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03818126.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call